A French company is preparing to test a complex artificial heart that combines biology with machinery.
Susan YoungFollow @twitterapi
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
In your DNA are clues to your health, your ancestry, and maybe even your purchasing preferences.
The mental fuzziness induced by cancer treatment could be eased by cognitive exercises performed online, say researchers.
Advanced genetic engineering is already changing vaccine development and could make inroads into other branches of medicine.
Artificial retinas give the blind only the barest sense of what’s visible, but researchers are working hard to improve that.
A biopharmaceutical company will know this year whether an antibody produced using a unique technique can prevent chronic migraines.
Genomics signatures in uterine cancers could offer clues to prognosis.
The impending Supreme Court ruling on gene patents is creating uncertainty in the molecular diagnostics sector.
A startup called Catabasis is developing drugs that hit diseases at multiple targets.